Drugstore chains in the USA may be as good as or better than mail-order pharmacists when it comes to finding the best price for prescription drugs, according to the New York Times, which notes that, to remain competitive, the chains are undercutting the prices of some of the most widely-used pharmaceutical products.
Someone buying a common maintenance medication such as Zantac (ranitidine) might be better off at a local discount store rather than dealing with the various drawbacks of mail-order, including turnaround time and possible improper use of medications, the NYT concluded.
Mail-order companies handled $6.8 billion or about 12% of the $56 billion in US prescription sales in 1992, according to Frost & Sullivan, which noted this is an increase of almost a third over the preceding year. The estimated savings from using mail-order range from a low of about 5% on some brands up to 40%. Michael Esposito of Arthur D Little said that while mail-order can offer significant savings for corporations and insurance plans, individuals buying on their own may find the savings more elusive.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze